Albiglutide TFA
CAS No. ——
Albiglutide TFA( —— )
Catalog No. M22524 CAS No. ——
Albiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 577 | In Stock |
|
| 10MG | 963 | In Stock |
|
| 25MG | 1424 | In Stock |
|
| 50MG | 2181 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlbiglutide TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlbiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).
-
DescriptionAlbiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGLP-1
-
Research AreaEndocrine system
-
IndicationDiabetes Mellitus, Type 2
Chemical Information
-
CAS Number——
-
Formula Weight3397.63
-
Molecular FormulaC150H225F3N40O47
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)C(F)(F)F.CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matthews JE, et al. Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008 Dec;93(12):4810-7.
molnova catalog
related products
-
HAEGTFT
HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
-
LGD-6972
LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist.
-
GLP-1R modulator L7-...
GLP-1R modulator L7-028 is a variant that enhances affinity for GLP-1 and (cAMP) signaling.
Cart
sales@molnova.com